tired on retatrutide and Joint Pain: Evidence, Risks, and UK Guidance – Bolt Pharmacy Retatrutide is being talked about

Preserved diluents containing benzyl alcohol are not routinely available in UK primary care settings and carry specific contraindications (for example, they must not be used in neonates or in patients with known benzyl alcohol sensitivity)

GLP-1 agonists are the focus of intense research for metabolic conditions

Weight loss plateaus are a recognised feature of anti-obesity pharmacotherapy generally and are a normal physiological response rather than necessarily a sign of treatment failure

In a report sent to clients this morning, Nephron MedTech analyst Chris Pasquale took a closer look at the relationship between weight and OSA and quantified the potential exposure sleep device makers like Inspire Medical and ResMed could face as GLP-1 use ramps